Science and Technology for Health: Towards Universal Access in a Changing World by Bloom, Gerald
Health
Science and Technology for Health:  
Towards Universal Access in  
a Changing World
Gerald Bloom
1970-2010
About the paper
Most anti-colonial movements in the second half of the 
20th Century promised to provide universal access to 
health services. The Alma Ata Declaration of 1978 
presented a consensus view of how governments could 
deliver on this promise. During the next thirty years, people 
experienced dramatic health improvements in some 
countries or districts, but they continued to suffer high 
levels of avoidable disease and early death in many others. 
The existence of effective health care technologies 
combined with the reality that hundreds of millions of 
people still do not have access to effective health services 
has led in recent years to national and international 
political pressure for action and significant funding to 
address this reality. This paper argues that effective 
strategies for increasing access to the benefits of 
health-related science and technology cannot just be 
viewed as technical challenges but must be grounded in 
the profound changes in political economy of the last thirty 
years. These include demographic shifts and changes to 
national and global economic arrangements, channels of 
knowledge flow, the organisation of politics and 
governance and the understanding of how innovations 
arise and are spread. Failure to take this into account could 
reduce the impact of these investments or even lead to 
unintended adverse consequences.
About the author
Gerry Bloom is a physician and health system analyst  
who leads the health/disease programme at STEPS.  
His special interest is health system transition in  
rapidly changing contexts.
About the Manifesto project
In 1970 a radical document called The Sussex Manifesto 
helped shape modern thinking on science and technology 
for development. Forty years on, we live in a highly 
globalised, interconnected and yet privatised world. We 
have witnessed unprecedented advances in science and 
technology, the rise of Asia and ever-shifting patterns of 
inequality. What kind of science and technology for 
development Manifesto is needed for today’s world? The 
STEPS Centre is creating a new manifesto with one of the 
authors of the original, Professor Geoff Oldham. Seeking to 
bring cutting-edge ideas and some Southern perspectives 
to current policy, the New Manifesto will recommend new 
ways of linking science and innovation to development for 
a more sustainable, equitable and resilient future.
For the all the papers in this series see:  
www.anewmanifesto.org
About the STEPS Centre
The STEPS Centre (Social, Technological and 
Environmental Pathways to Sustainability) is an 
interdisciplinary global research and policy engagement 
hub that unites development studies with science and 
technology  studies. Based at the Institute of Development 
Studies and SPRU Science and Technology Policy Research 
at the University of Sussex, with partners in Africa, Asia and 
Latin America, we are funded by the Economic and Social 
Research Council.
Find out more at www.steps-centre.org
This is one of a series of Working Papers from the STEPS Centre
www.steps-centre.org
ISBN:  978 1 85864 787 8
© STEPS 2009
IDS_Master Logo
  
 
 
 
 
Science and Technology for Health: 
Towards Universal Access in a Changing 
World 
 
 
 
Gerald Bloom 
 
   
 
2 
 
Correct citation: Bloom, G. (2009) Science and Technology for Health: Towards Universal Access 
in a Changing World, STEPS Working Paper 28, Brighton: STEPS Centre 
 
First published in 2009 
© STEPS 2009 
Some rights reserved – see copyright license for details 
 
ISBN 978 1 85864 787 8 
 
The author would like to acknowledge the many discussions with members of the STEPS Centre 
which contributed to this paper and he would particularly like to acknowledge the extremely 
helpful comments and suggestions by Hilary Standing. The time he allocated to this paper was 
jointly funded by grants by ESRC to the STEPS Centre and by DFID to the Future Health Systems 
Research Programme Consortium. The author is solely responsible for the opinions expressed. 
 
The author expresses his appreciation for the financial support (Grant # H050474) provided by 
the UK Department for International Development (DFID) for the Future Health Systems 
research programme consortium. The views expressed are not necessarily those of DFID. 
 
Thanks to Elisa Arond and Harriet Le Bris for help with copy-editing.  
 
Cover design by Barney Haward. 
 
For further information please contact: STEPS Centre, University of Sussex, Brighton BN1 9RE 
Tel: +44 (0) 1273606261 
Email: steps-centre@ids.ac.uk 
Web: www.steps-centre.org 
 
STEPS Centre publications are published under a Creative Commons Attribution – Non-
Commercial – No Derivative Works 3.0 UK: England & Wales Licence 
(http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode) 
 
Attribution: You must attribute the work in the manner specified by the author or licensor. 
Non-commercial: You may not use this work for commercial purposes. 
No Derivative Works: You may not alter, transfer, or build on this work. 
 
Users are welcome to copy, distribute, display, translate or perform this work without written 
permission subject to the conditions set out in the Creative Commons licence. For any reuse or 
distribution, you must make clear to others the licence terms of this work. If you use the work, 
we ask that you reference the STEPS Centre website (www.steps-centre.org) and send a copy of 
the work or a link to its use online to the following address for our archive: STEPS Centre, 
University of Sussex, Brighton BN1 9RE, UK (steps-centre@ids.ac.uk). 
 
 
   
 
3 
 
CONTENTS 
 
CONTENTS ............................................................................................................................................................................ 3 
INTRODUCTION ................................................................................................................................................................... 4 
THE ALMA ATA DECLARATION: A POST-COLONIAL AND POST-REVOLUTIONARY CONSENSUS .... 4 
DIRECTIONALITY ............................................................................................................................................................ 5 
DISTRIBUTION ................................................................................................................................................................. 5 
DIVERSITY ......................................................................................................................................................................... 6 
THE CHANGING REALITY ................................................................................................................................................. 7 
BUILDING INNOVATION CAPABILITIES IN HEALTH .............................................................................................. 9 
NEGLECTED DISEASES, NEW PROGRAMMES AND THE DIRECTION OF RESEARCH ............................ 11 
RESPONDING TO THE SPREAD OF HEALTH-RELATED MARKETS ............................................................... 13 
CONSUMERS, CITIZENS, INFORMATION AND RIGHTS ..................................................................................... 15 
NEW TECHNOLOGIES AND NEW POSSIBILITIES FOR THE SPREAD OF INNOVATIONS ...................... 15 
REFERENCES...................................................................................................................................................................... 17 
   
 
4 
 
INTRODUCTION 
This paper is a contribution to the preparation by the STEPS Centre of a Sussex Manifesto on the 
inter-relationship between science, technology and development. The present manifesto 
follows a previous one published in 1970 and explores the implications of the changes which 
have subsequently occurred for its conclusions and recommendations. The manifesto frames its 
analysis and policy implications in terms of directionality - the factors that influence the types of 
technology that are developed and widely adopted; distribution - the influence of the 
technologies on the division of benefits between population groups; and diversity - the degree 
to which technologies adapt to different contexts. The paper on health is one of several 
background documents that draw on experiences and ideas from different sectors. 
 
The development of effective medical care has long been considered an important benefit of 
scientific knowledge and associated technologies. This perception was reflected in the promise 
by almost every anti-colonial and revolutionary movement of the second half of the 20
th
 Century 
to increase access to health services substantially. More recently it has been reflected in major 
international programmes aimed at reducing the burden of avoidable illness and premature 
death. This paper describes the changing understandings over the last three decades of how the 
benefits of medical knowledge and specialised health care technologies can be spread rapidly. It 
begins with the Alma Ata Declaration, which was signed several years after the publication of the 
first Sussex Manifesto. It then describes the many demographic, technological and social 
changes that have altered our understandings about how knowledge is generated and 
translated into technologies that provide widespread benefits. The paper’s aim is to explore how 
the themes of the present manifesto are reflected in the health sector. 
THE ALMA ATA DECLARATION: A POST-COLONIAL AND POST-
REVOLUTIONARY CONSENSUS 
In 1978, several years after the publication of the Sussex Manifesto, the World Health 
Organisation (WHO) and the United Nations Children’s Fund (UNICEF) convened a major meeting 
on health policy, which resulted in the so-called ‘Alma–Ata Declaration’ (WHO 1978). The site of 
the event in a ‘developing’ republic of the now former Soviet Union symbolised its role in 
bridging perspectives across the Cold War divide. The declaration outlined the implications for 
the health sector of the widely held belief that the state could lead the creation of a modern 
economy capable of spreading the benefits of science and technology rapidly.  
 
The principal focus of the Alma Ata Declaration was how to achieve ‘health for all’ in the context 
of high levels of illness and premature death amongst the poor, despite the availability of 
knowledge and inexpensive technologies to address many of these problems. It highlighted the 
inter-relationship between sickness and poverty and the potential importance of measures to 
ensure that people have access to adequate nutrition, decent housing, clean water and medical 
care free at the point of delivery. This was a re-statement, from the point of view of health, of the 
importance of meeting ‘basic needs’ (ILO 1977).1  
 
                                                          
1
 The recent report by the WHO Commission on the Social Determinants of Health (WHO 2008a) similarly 
emphasizes the many factors that influence health outcomes. 
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The Declaration is best known for establishing the principles and philosophy of comprehensive 
primary health care (PHC) for spreading the benefits of modern health care technology through 
a functioning set of linkages from local health centres dealing with prevention and basic curative 
care to hospitals. This approach drew on different experiences and traditions including (i) some 
colonial health services, which organised low cost preventive services and basic curative care, 
relying on paramedical personnel; (ii) the American experience of large-scale public health 
campaigns to control yellow fever, malaria and other diseases; (iii) anti-colonial political 
movements in many African and Asian countries, which built a political consensus in favour of 
expanding access to health services and (iv) revolutionary movements and post-revolutionary 
regimes,, which mobilised populations in public health campaigns and rapidly expanded access 
to basic health services. The following paragraphs address the Alma Ata Declaration in terms of 
directionality, distribution and diversity.  
DIRECTIONALITY  
The Declaration established access for all to PHC as the agreed aim of international health 
development, thereby indicating a uniform direction for health policy, at least in theory. This was 
a sharp shift from the health sector development strategies of many post-colonial countries in 
the 1960s and 1970s, which had focused on building referral hospitals and establishing medical 
schools. With the Alma-Ata Declaration, the pattern of donor funding and, to some extent, public 
sector investment shifted towards community-based services. Typical health development 
strategies included construction of a network of health clinics and community hospitals, training 
and deployment of paramedical personnel, creation of a capacity to procure and distribute a 
relatively small number of essential drugs and the establishment of public health programmes. 
There was an emphasis on prevention, particularly maternal and child health services. One 
innovative aspect of health development strategies in many countries was the training and 
deployment of community health workers, who were expected to lead public health activities 
and/or provide basic health care at community level. In practice, the direction of health system 
development diverged greatly between countries depending largely on the degree to which the 
government prioritised meeting the needs of the majority of the population and resisted efforts 
by the rich and powerful to influence health system development (Farmer 2005). Nonetheless, 
many countries succeeded in establishing a basic functioning PHC infrastructure. 
DISTRIBUTION  
Following the Alma-Ata Declaration, PHC strategies emphasised the need to expand access to 
basic health services and shift the allocation of public and donor resources in favour of the poor. 
There were notable examples of expansion of access to health services and improvements in 
health. These included post-colonial regimes in Malaysia, Sri Lanka and Kerala State, India, and 
command economies in China, Vietnam and Cuba. These successes contributed greatly to the 
international influence of the primary health care strategy (Halstead, Walsh and Warren 1985). In 
many other countries the allocation of government development and recurrent finance did not 
reflect the priority ostensibly given to PHC and inequalities in access to health-related resources 
widened.  
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DIVERSITY  
The Alma Ata Declaration accepted a variety of approaches for increasing access to health 
services, emphasising the importance of public participation in health activities and 
acknowledging the potential role of traditional health care practices and practitioners. 
Nonetheless, it emphasised government’s responsibility for organising and financing health 
systems. The translation into practice of the broad principles of PHC largely took the form of 
government investment programmes and a rapid expansion of public sector health services 
managed (at least in theory) as command and control organisations. Community participation 
was mostly limited to the creation of local health committees to provide voluntary inputs to 
public health programmes or, less commonly, to act as guardians of accountability.  
 
As in other sectors, the consensus strategies for health system development were strongly 
influenced by the predominant belief that the state could, and should, lead the creation of a 
modern economy. This belief drew on the successful rebuilding of Western Europe with support 
from the Marshall Plan, the rapid post-revolutionary reconstruction and development of a 
number of command economies and the success of a number of populist regimes in spreading 
the benefits of development. The Alma Ata Declaration identified the key elements of a state-led 
strategy for achieving rapid expansion in prevention and treatment of the common health 
problems, largely framed in terms of overcoming severe shortages of physical infrastructure, 
equipment, trained personnel and drugs and other consumable items. The creation of expert 
knowledge and new equipment and pharmaceuticals were mainly seen to take place outside 
developing countries. The role of health system leaders in these countries was largely to select 
the most appropriate technologies and make them widely available through a state organised 
health service. There were exceptions to this view of the flow of innovation. Many health services 
included innovations in the mix of personnel
2
 and the role of community organisation. Some low 
cost interventions, such as the use of oral rehydration solution to treat diarrhoea, were 
developed and tested in low income countries. In some countries traditional health practitioners 
were seen to be a source of health-related knowledge. China integrated them into its 
government health system and promoted effective treatment methods such as acupuncture 
and certain drugs. In most other countries, such as India, traditional systems operated in parallel 
to the government health system, playing a variable role in official policies and development 
strategies.  
 
Subsequent debates about health system development have been largely predicated on this 
understanding about the source of new knowledge and technologies and about the 
predominant role of state organisations in making the benefits of them available to the 
population. There have been variations in the implications for government policies and 
strategies. The World Health Assembly agreed a target of achieving ‘Health for All by 2000’, 
envisaging government health systems, which organised and financed a full mix of services for 
all. Other agencies advocated ‘selective primary health care’, focusing on a limited number of 
programmes, with a largely unspoken implication that people would not have access to other 
services or would purchase them from private practitioners (Walsh and Warren 1979). For 
example, the 1993 World Development Report (World Bank 1993) emphasised the need to select 
the most cost-effective services to be financed and organised by government. That report 
                                                          
2
 The reliance on paramedical personnel with shorter periods of training was influenced by the experience 
of the Soviet Union with the training of so-called feldshers (preventive and primary health care 
professionals) and of colonial health services, who trained medical assistants and health assistants to 
provide services to the ‘natives’.  
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suggested that governments introduce charges for some services to compensate for shortfalls 
in public finance, launching a debate which has continued to the present (Alliance for Health 
Policy and Systems Research 2004). That document, too, focused largely on ways to incorporate 
imported expert knowledge, drugs and equipment into government-run health services. Later 
still the emphasis shifted to the achievement of a small number of health-related Millennium 
Development Goals and the potential benefits of scaling up interventions which had been shown 
to be effective and cost effective. Despite the heated debates and strong competition for policy 
leadership between different UN and bilateral agencies, there has been a shared understanding 
about the major sources of innovation and the key role of government in delivering basic health 
services. Meanwhile, many countries experienced a rapid growth in markets for health-related 
goods and services (Mackintosh and Koivusalo 2005; Bloom et al 2009). 
 
During the 1980s analysts of health systems in the advanced market economies became 
increasingly interested in the working of health markets in response to growing concerns about 
rising costs of health care and to a broader shift in views about the role and capacity of 
government. This contributed to highly publicised reforms, which attempted to introduce 
aspects of markets into publicly financed health services. The writings on health and health 
policy in low and middle income countries began to import this language. Two World Bank 
publications (Akin et al 1987 & World Bank 1993) were particularly influential in suggesting that 
certain services were more efficiently provided through markets and arguing that public services 
should focus on increasing access to only a bundle of cost-effective services. Subsequently, 
there was a growing interest in the role of NGOs in the provision of health services, in the role of 
markets in organising the provision of services the government could, or would not fund, and in 
the potential role of user charges as a means of rationing access to services. Highly organised 
health systems began to experiment with changing the ownership and governance of hospitals, 
contracting out some services, providing public funding to not-for-profit hospitals and so forth. 
The recognition that the government was no longer the sole provider and funder of health 
services contributed to the gradual emergence of the concept of ‘stewardship’ to describe a new 
role of government as overall guide to the development of the health system (Saltman and 
Ferroussier-Davis 2000). 
 
Through out this time, there was a rumbling competition amongst UN and bilateral donors, 
which supported different views about the relative roles of public and private sectors in the 
provision of health services and the generation of appropriate innovations. At times this surfaced 
as a competition between ‘American’ and ‘European’ visions of the future health systems of 
developing countries. American agencies had a greater preference for working with private 
actors, whilst Europeans tended to favour so-called sector-wide approaches and budgetary 
support programmes which transferred funds to government budgets. The former Soviet Union 
and Cuba also supported certain countries promoting a vision of a state run health system. The 
underlying assumption was that ‘America’, ‘Europe’ and ‘Communism’ provided competing 
visions of the future health systems for the rest of the world. This vision of a future that mostly 
resembled the past has, to a large extent, been overtaken by a sequence of events which have 
shaken the credibility of each of these visions.  
THE CHANGING REALITY 
The various Manifesto background papers highlight many changes in global development. These 
include: the divergent development experiences of different countries; the shift in the relative 
balance between states and markets; the emergence of China, India and other countries as 
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centres of innovation; the rise of new information and communications technologies; the 
emergence of increasingly powerful NGOs and citizen groups as development actors; and the 
shift in the role of development aid from a time-limited investment in physical and human 
capital to longer-term commitments to co-finance services for the poor and the adaptation to 
an ecologically sustainable development path. These changes and others have strongly affected 
health and health systems. The present economic and financial crises associated with the end of 
an American-led vision of the economic and political future is making many of these changes 
more manifest in policy debates. The so-called ‘Washington Consensus’ on the relative roles of 
states and markets is no longer the dominant way to frame either the new challenges, or the 
policy options for addressing them. 
 
Since the Alma-Ata Declaration, health and the health systems of many countries have changed 
radically, mirroring their divergent development experiences. There are wide differences in 
health status and access to health services associated with parallel differences in economic and 
social development (Bloom et al 2007). It is now much more difficult to make general 
statements about such different contexts, although one can identify a number of major trends. 
The 2008 World Health Report, which returns to primary health care thirty years after the Alma-
Ata Declaration, identifies several of these trends (WHO 2008b). 
 
During this time most countries have experienced big population increases and a changing 
demographic profile, with many more people over the age of sixty. There has been rapid 
urbanisation. The ageing of the population, economic growth, changes in types of work and 
lifestyles, the relative success of efforts to reduce childhood mortality and, in many cases, a 
reduction in the proportion of people living below the poverty line have been associated with a 
dramatic rise in the burden of chronic, non-communicable diseases. Some counties are 
experiencing a ‘double burden’ of the infectious diseases of poverty and a growing prevalence of 
chronic illness. Other countries have been much less successful in reducing poverty and they 
continue to experience health problems associated with chronic poverty, lack of access to clean 
water, poor sanitation and inadequate housing. Some have experienced a serious fall in life 
expectancy associated with the spread of HIV. Others, in the former Soviet Union, have 
experienced increased mortality from non-communicable diseases (Bloom et al 2007). These 
changes strongly influence the demand for innovations in technology and the organisation of 
health systems. 
 
A second change is a direct consequence of the major investments in health sector 
development. Very few localities are far from a health facility or someone offering medical 
advice, treatment and a wide variety of drugs. In many countries there has been a dramatic 
spread of market relationships, leading to the emergence of pluralistic health systems with a 
wide variety of providers of health services and drugs in terms of training, legal status and 
ownership (Bloom and Standing 2001). The spread of markets has been associated in a number 
of countries with economic and political crises, chronic underfunding of the public health 
system and a blurring of the boundaries between public and private sector, with health workers 
combining government employment with a variety of market-like activities. In the ex-command 
economies of Europe and the former Soviet Union, it has been associated with severe resource 
constraints in the public sector and the rise in economic inequalities. In many Asian countries it 
has been associated with rapid economic growth and a rise in demand for health-related goods 
and services that has outstripped the rise in public funding of government services. In most 
cases the spread of markets has been much faster than the creation of institutional 
arrangements to encourage them to perform well. This has led to major problems with 
effectiveness, safety, cost and access to competent services by the poor. Whereas thirty years 
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ago the major challenge was an absolute scarcity of buildings, personnel and equipment, many 
people, particularly in urban areas, now have access to a bewildering variety of providers of 
services and health-related products. Their main challenges concern the choice of appropriate 
goods and services and their high cost. At the same time, many people still do not have access 
to health-related goods and services as a result of severe poverty, remote location or endemic 
conflict.  
 
A third change has been the creation of many channels for the spread of health-related 
knowledge. It is no longer plausible to perceive government services and information provision 
as the principal sources of health-related knowledge. This knowledge is now spread through 
schools, health worker (and community health worker) training programmes, informal markets, 
the electronic and print media, mobile telephones and the internet. There are now many 
creators of content for these media, including government agencies, newspapers and television 
production companies, private corporations, advertising agencies, advocacy groups and an 
increasing variety of providers of internet content. People have access to a lot of information, 
including informalised knowledge through an increasing array of purveyors of market-based 
goods and services.  However, they need to assess the accuracy of information and the motives 
of its providers. This information can sometimes raise expectations about the capabilities of 
modern medicine and at other times, it can lead to fears and anxieties.  
 
A fourth change has been in the types of organisation involved in the health sector, which now 
include different kinds of private company (national and international producers of equipment 
and pharmaceutical products, branded hospital chains and so forth), not-for-profit organisations, 
associations of health workers and health-related businesses, citizen groups and disease-
specific advocacy groups. National governments have a limited capacity to determine the 
direction of development of the health system and they increasingly rely on different types of 
partnership with other actors.  
 
A fifth change has been in the role of international organisations, bilateral aid agencies and large 
foundations as sources of health finance in low income countries. These institutions now 
provide financial transfers through disease-specific programmes, budgetary support for 
government health systems and substantial investments in new technologies and new health 
system interventions. These have had a major impact on national policy directions, leading to 
concerns that they may distort priority setting by national governments. 
 
These changes have taken place at local, national, regional and global levels. The previous vision 
of a simple chain of transmission of innovation from specialised centres in a few developed 
countries to government-led health systems, solely through some adaptations of technology 
and delivery systems to local contexts, no longer provides a convincing vision of a much more 
complex reality. It also does not reflect the importance of decisions by actors at every level in 
influencing the pathways of development of health systems. The remainder of this paper 
discusses some approaches that have emerged for expanding access to the benefits of health 
care technologies and the degree to which they take into account the changed reality and new 
thinking about the interaction between science, technology and development. 
BUILDING INNOVATION CAPABILITIES IN HEALTH 
During the past decade there has been growing concern at international level about the failure 
of many countries to achieve their health-related MDGs. This has led to financial commitments 
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by the governments of high income countries and by several foundations to support 
improvements in access to health services. There has also been a growing interest in investing in 
appropriate innovations. The Global Forum for Health Research has organised several meetings 
of Health Ministers to discuss strategies for overcoming the ‘90/10 gap’ describing the present 
allocation of health research funds in which ninety percent of global funding for health-related 
research focuses on the health problems of ten percent of the global population (Global Forum 
for Health Research 2003). A number of initiatives have been launched to address this problem.  
 
The paper by Martin Bell (2009) argues for a greater recognition that innovation takes place both 
in specialised research centres and in organisations at every level of the value chain, in the form 
of minor modifications to a new technology. The paper provides a useful framework for 
discussing health-related innovations; however Bell’s innovation systems framework needs to be 
extended to take into account the dual functions of the health sector as a producer and 
distributor of specialised goods and a provider and organiser of services. One can identify a 
variety of types of health-related innovation including (i) basic science aimed at generating new 
knowledge about humans, the development of diseases and potential mechanisms to alter 
disease processes, (ii) research and development aimed at developing new kinds of equipment 
and pharmaceutical products, (iii) the design of interventions, which apply expert knowledge and 
new drugs and equipment to a specific health problem, (iv) ways to draw on local knowledge of 
effective ways to prevent, live with and treat disease, (v) the development of organisations and 
institutional arrangements to make the benefits of expert knowledge widely available in different 
contexts, (vi) broader studies of the interactions between humans and their environment (social, 
economic and ecological), and the impact on human health, and (vii) the creation of new ways to 
make expert knowledge available to individuals and mass populations. 
 
Bell’s characterisation of mainstream approaches for supporting innovation as focusing almost 
exclusively on specialised research and development organisations reflects the dominant 
pattern of investment in health-related innovation. Investments have tended to focus on 
science-based research and development and the development of well-designed interventions 
for potential scale-up in multiple contexts. There has been much less investment in building 
‘down-stream’ innovation capabilities. The language of ‘scaling-up’ implies a major distinction 
between innovation and diffusion. Although there have been efforts to strengthen management 
of hospitals and specific disease programmes they have focused only to a limited extent on the 
need to innovate or learn from good and bad local practices. There has been even less 
investment in learning from innovations by private providers of medical care and drugs, 
particularly those working outside a regulatory framework. In many countries, much 
downstream activity takes place outside a regulatory framework and is largely ignored by policy-
makers.  
 
Bell’s rejection of the contrast between the ‘rapid impact of research and development-based 
innovation and scaling up’ and the ‘slow impact of investments in capabilities to incorporate 
small adaptations at all levels’ is pertinent to the health sector. The search for measurable and 
rapid impact has led to a preponderance of investment in potentially major new technologies 
and in innovations which could be replicated rapidly. This has also reflected the dominance of 
the clinical sciences and the tendency to look for a ‘medical fix’ in response to complex 
problems. There has been much less investment in the many actors who play an important role 
in the provision of health-related goods and services to poor people. Bell’s argument about the 
need to combine the importation of technologies with support for building local capabilities to 
incorporate small adaptations is highly salient to the health sector. It suggests that investment in 
only one element of the chain in order to translate new scientific knowledge into widespread 
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access to an effective technology will have limited impact and may lead to unanticipated 
consequences. 
 
A large proportion of health-related investments by governments and foundations has been on 
the development of new equipment, pharmaceuticals, vaccines and ‘cost-effective 
interventions’, which local health systems could import. This has led to support for a variety of 
centres of excellence, mostly public sector research institutions and large private companies. 
There has been much less investment in small-scale researchers and innovators in low and 
middle income countries (Light 2009).
3
 The need to invest in the design and management of 
these innovations has fostered the creation of new international agencies such as GAVI and the 
Global Fund for HIV and AIDS, Tuberculosis and Malaria and new centres for global health, funded 
largely by the Gates Foundation in the United States.  
 
There has also been a significant investment in the creation of centres of excellence in health 
system analysis in a number of countries. One interesting model is the World Bank Institute, 
which established centres of excellence in health economics, with several regional flagship 
courses. There are similar networks of centres of excellence in clinical epidemiology and 
demographic surveillance sites, which collect systematic information on health and health 
seeking behaviour. A recent initiative by the Gates Foundation has twinned American and African 
public health research and training institutes with the aim of building the capacity of the latter. 
One can see interesting parallels between these initiatives of the Gates Foundation and those of 
the early 20
th
 Century, when the Carnegie Foundation and others made major investments in 
science-based medical schools in the United States (Starr 1982) and the Rockefeller Foundation 
invested in building the capacity for public health research and interventions in the Americas. In 
contrast, there has been much less investment in building the capacity of local actors in low and 
middle income countries, including government health systems and private actors, to learn from 
their own experience and draw on this learning to support the creation of appropriate 
institutional arrangements for good performance.  
NEGLECTED DISEASES, NEW PROGRAMMES AND THE DIRECTION OF 
RESEARCH 
There have been major investments in health-related innovations over the past decade. This 
section outlines some of the successes and some of the problems which are emerging because 
of the partial nature of the strategies for building innovation capabilities.  
 
There has been a lot of investment in strategies for translating existing technologies for the 
treatment of tuberculosis and HIV/AIDS, and for immunising children against infectious disease, 
into organisational arrangements to provide very wide access to these technologies. These 
programmes have been designed along bureaucratic lines with a direct line of command from 
the top to individual implementers and users. The aim has been to ensure the provision of a 
replicable intervention, such as the delivery of a vaccine or the provision of specific course drug 
treatment. There are persistent debates about the impact of these programmes, but there is 
little doubt that they have increased access to services.  
                                                          
3
 Light (2009) describes how the design of advanced market commitments, led by the Gates Foundation, 
to encourage research and development of new vaccines has tended to reinforce existing international 
property arrangements and favour the R&D departments of large pharmaceutical firms rather than smaller 
biotechnology companies. 
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A number of questions have also been raised about the applicability of this approach, where 
many health-related transactions take place in unorganised markets. For example, there are 
serious questions about the feasibility (in terms of resources and personnel) of the plans to 
extend current models for organising the treatment of HIV and AIDS to provide universal access. 
Van Damme et al (2008) suggest that more attention should be paid to the development of 
solutions that take resource and human constraints and local contexts into account. There are 
questions about possible risks of unintended consequences. For example, the introduction of 
expensive drugs into environments with largely unregulated markets could lead to a 
considerable amount of leakage, with deleterious consequences for equity of access and the 
emergence of drug resistant organisms. There are growing problems with bacteria and viruses 
that are resistant to standard therapies. There are also issues around local understandings of the 
intervention and how that influences the behaviour of users and providers of services. For 
example, competing narratives about the true purpose of the polio eradication programme in 
Northern Nigeria seriously disrupted its implementation (Yahya 2006). These examples highlight 
the need to complement investment in R&D with measures to adapt interventions to local 
contexts. 
 
The recent experience with artemisinin illustrates the strengths and weaknesses of current 
strategies for supporting health-related innovation. The Artemisia plant is a traditional Chinese 
remedy for malaria. Interest in it grew as the malaria parasite developed resistance to the 
available anti-malarial products. This led to investment in the cultivation of artemisia plants and 
production of the pharmaceutical product, artemisinin. A number of countries now recommend 
that people take artemisinin as a drug of choice, when they have the symptoms of malaria and 
international experts recommend that it be combined with another anti-malarial drug to reduce 
the risk of the emergence of malaria parasites resistant to artemisinin (WHO 2006). Artemisinin, 
on its own, and as artemisinin combination therapy (ACT) are now widely available. They are 
significantly more expensive than the older products, to which resistance is now widespread. 
 
The Roll Back Malaria initiative advocates the purchase of large amounts of ACT to be supplied 
free of charge or at a highly subsidised price (WHO 2006). However, most countries have not 
achieved anywhere near universal access to subsidised ACT. In many countries, people buy anti-
malarial medications from drug stores or informal drug sellers, which function largely outside 
the national malaria programme; a recent study in Nigeria found that people purchased drugs 
from patent medicine vendors or treated themselves in more than half the cases (Oladepo et al 
2007). It also found that the shops mostly stocked the cheaper products to which a substantial 
proportion of malaria parasites are resistant. The study found several reasons for the persistent 
use of products that were becoming obsolete. One was that government did not target its 
messages about malaria treatment to these drug sellers. Another was popular distrust of the 
reasons for the sudden decision by government to recommend that people purchase a much 
more expensive product. At that time, donor programmes to supply subsidised ACT were just 
getting underway.  
 
The situation is similar in Cambodia, where people have had access to artemisinin for years. 
Studies have found that a significant proportion of anti-malarial drugs in that country are fake or 
sub-standard (Dondorp et al 2004). There has been growing evidence of the emergence of 
organisms resistant to artemisinin in Cambodia (Dondorp et al 2009). In June 2009, the Gates 
Foundation announced that it had made a grant of twenty million dollars to a worldwide anti-
malarial resistance network, to avert the major consequences of the spread of resistance to 
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artemisinin.
4
 This experience illustrates the need to frame health-related innovation systems 
widely to reflect the many factors which influence the outcome of an investment decision. In the 
case of malaria, this may include the ecology of the interaction between malaria parasites and 
different drugs, the organisation of wholesale and retail markets for different anti-malarial 
products and the understandings of providers and users about how to use alternative products 
and about their responsibilities for preventing the emergence of resistance. The design of an 
innovation strategy needs to address each factor that is likely to influence the short and longer 
term outcome.  
RESPONDING TO THE SPREAD OF HEALTH-RELATED MARKETS 
One of the most dramatic changes in global health systems has been the rapid spread of health-
related markets. They have tended to be rather chaotic and poorly regulated. A significant 
proportion of health-related transactions now take place outside an organised environment 
(Bloom et al 2009).  One of the major challenges for the next few years will be to establish 
appropriate institutional arrangements to influence the performance of these markets. This 
raises important questions about where new types of organisation and institutional arrangement 
arise.  
 
The advanced market economies have spawned a number of organizational models for bringing 
order to health-related markets. These include chains of retail pharmacies or hospitals, and 
franchises for a variety of health-related products. These models are diffusing through the 
expansion of organizations to other countries and by replication of these models by local 
entrepreneurs. Several donor programmes have attempted to adapt these models to meet the 
needs of the poor, but there is little evidence about the degree to which these programmes have 
been successful in altering health market systems substantially (Champion et al 2009). However, 
the recent growth in retail pharmacy chains in a number of countries and the increasing 
importance of trans-national hospital chains suggest they may expand rapidly in the future. 
 
The rapid economic growth of China, India, Brazil and other countries is creating new 
international centres for technological innovation (Mashelkar 2005; Leadbeater & Wilsdon 
2007). The demand for health-related goods and services is rising rapidly in these countries. 
Prahalad (2005) argues that the rapid integration of many people, with relatively low incomes, 
into national markets is likely to create a demand for inexpensive ways to meet their needs. 
Kaplinsky (2008) and Leach and Scoones (2006) emphasise that low cost innovations are more 
likely to emerge near to the markets. Several analysts suggest that these innovations may 
disrupt existing institutions. Light (2004) draws a parallel between the impact on relationships 
between market actors of a major social and economic change, such as the rapid spread of 
markets, and the emergence of a so-called ‘disruptive technology’, such as the internet. Both put 
a premium on entrepreneurship and the development of informal relationships to support 
innovative business models. Light describes the emergence in transitional economies of hybrid 
organisations that are neither public nor private and suggests that they could rapidly establish 
new market niches and ultimately alter the governance of existing value chains. Clarke et al 
(2009) emphasise the potential importance of ‘under-the-radar’ innovations in response to the 
rapidly rising demand for low cost goods and services. The combination of rapid rises in demand 
                                                          
4
 WHO press release, February 2009, available at: 
www.who.int/mediacentre/news/releases/2009/malaria_drug_resistance_20090225/en/index.html, 
accessed 10 September  2009 
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for new types of goods and services with the growing capacity for innovation in a number of 
countries suggests the likely emergence of quite different types of organization that reflect 
current technologies, the economic and social context and the regulatory environment in these 
countries. If these companies can build a reputation for providing trustworthy services at an 
affordable price, they could expand very rapidly to become important actors in the global health 
economy and disrupt existing value chain governance arrangements. 
 
Social entrepreneurs are playing a growing role in health-related markets.
5
 In some cases, their 
focus has been on establishing new niches, which ultimately could be filled by other market-
oriented organizations; in other cases, the focus is on raising money to finance services that 
reach the poor. One example of the work of a social entrepreneur is the design and production 
of low cost eyeglasses for people with age-related vision problems and the development of 
systems to distribute them. Scojo, a social enterprise, has led the latter in India and a number of 
other countries. It has established its own distribution network in some cases but elsewhere it 
has linked to organizations that already have a local distribution network. In Bangladesh, for 
example, it is working with BRAC, a very large NGO with a major health programme. BRAC has 
trained many village health volunteers, who, amongst other things, have played an important 
role in the implementation of directly observable therapy for tuberculosis. A recent review of 
BRAC’s experience with female community health volunteers has emphasized the importance of 
BRAC’s good reputation in motivating them, but it identified the need to ensure they can also 
earn some money and maintain a livelihood in a context where there are increasingly other 
opportunities for them to earn a living (Standing & Chowdhury 2008). Distribution of low cost 
eyeglasses would serve both a growing need in rural populations and provide income for its 
health volunteers. Scojo, on the other hand stands to benefit from the established network and 
BRAC’s good reputation.  
 
The boundary between social entrepreneurship and responses to commercial opportunities can 
shift. For example, banking through mobile telephones has evolved from being an act of social 
entrepreneurship to a major business opportunity. The same applies to micro-credit. A recent 
assessment of micro-credit confirms its success in achieving growth in access by people 
previously excluded from the organised economy (Greeley 2006). It has substantially improved 
the performance of credit markets by using innovative approaches for identifying good credit 
risks, appropriate to the institutional context of many low-income countries. Successful 
schemes are linking to commercial financial organizations. This in turn may create new ways of 
delivering insurance based health protection. It is possible that a similar process is emerging in 
the health sector, where social entrepreneurs are investing in the development of innovative 
approaches for responding to major unmet demands for services. If they are successful, they 
may pave the way for commercial organisations to move into the newly created market niches 
and for government and new kinds of social organisations to respond to the needs of the very 
poor. 
                                                          
5
 The term is usually used to refer to a focus on the creation of social value and a number of attributes of 
innovation, risk taking and a willingness to try something new (Peredo  and  McLean 2006; Weerawardena  
and  Mort 2006). An alternative definition refers to organizations that ‘borrow a mix of business, charity 
and social movement models to reconfigure solutions to community problems and deliver sustainable 
new social value’ (Nicholls 2006:2) 
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CONSUMERS, CITIZENS, INFORMATION AND RIGHTS 
There has been a dramatic increase over the past thirty years in the channels of flow of health-
related information and in the number of providers of content for these channels. The spread of 
health-related markets has meant that people have had much more choice in how to deal with a 
health problem. They have also been relatively unprotected from unscrupulous practices. There 
is a growing recognition that people are active participants in their health care. Leonard et al 
(2009) demonstrate how rural people seek information on local health service providers and 
select those believed to perform well. Mackay (2008) argues that the tools of marketing and 
consumer research can be used to understand many decisions concerning health care. These 
tools are already used by commercial organizations.  
 
The emergence of these markets has occurred more rapidly than the development of 
organisations and institutions to protect the rights of consumers. This is changing. There is a 
growing understanding in many countries that all citizens are entitled to access to safe and 
competent health services. This understanding has been manifested in a number of ways. Peters 
and Muraleedharan (2008) describe the increasing role of consumer advocacy groups in India. A 
number of countries have experienced a rise in the use of malpractice law. There is growing 
pressure on some governments to regulate the quality of drugs and the safety of food. However, 
the institutions for protecting these rights are quite under-developed in many countries. 
 
There has also been a growth in a variety of advocacy and citizens groups aiming to influence 
health system performance. For example, a number of groups have been organised to alter 
government policies towards the treatment of people with HIV and AIDS (Nguyen 2005; Robins 
2005). Citizen groups now play an important role in negotiating policy in some countries. 
Another change since the late 1970s has been the growth of large NGOs, which raise funds and 
attempt to influence national policies and the global health community.  
NEW TECHNOLOGIES AND NEW POSSIBILITIES FOR THE SPREAD OF 
INNOVATIONS 
This final section touches on the potential role of new technologies in creating possibilities for 
major changes in the organisation of health systems. There are signs that developments in 
information and communications technologies are beginning to disrupt existing arrangements 
for the governance of health and its value chains. Lucas (2009) highlights three major areas of 
potential impact. 
 
The first is the use of mobile telephones and other communications media to provide access to 
expert advice for health service providers and the general public. Some innovations already 
provide a service for a large population.  One example is the provision through major mobile 
telecoms providers in Bangladesh of health helplines that provide callers with access to quality 
assured advice from qualified doctors for a relatively modest call fee. Bangladesh has a high 
density of mobile phone access even though ownership levels remain limited. There is some 
evidence that informal providers also use the service to obtain expert advice to assist them in 
treating their patients.
6
 
                                                          
6
 Personal communication to a workshop in Dhaka by SI Sikdar, Grameenphone Ltd, Dhaka, Bangladesh 
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The second is the use of information technology to strengthen the management of health 
services. This includes its use for basic accounting and billing, but also as a means of monitoring 
the quality of service and guideline diagnosis and treatment. One well documented example is a 
chain of clinics in South Africa, which used embedded algorithms to ensure that people received 
appropriate drugs for their diagnosis (Palmer et al 2003). Other examples include retail pharmacy 
chains and several franchising arrangements. Once expert systems, which guide the diagnosis 
and treatment of common conditions, are widely available they have a great potential for 
reducing the variability of treatment and could substantially improve the quality of services. 
 
The third is the development of sources of expert knowledge, which individuals can access 
directly through the internet. This opens up major opportunities for people to manage their own 
disease and seek expert opinions on alternative treatments. Lucas (2009) emphasises the 
opportunities this could provide to firms wishing to influence behaviour in their commercial 
interest. He highlights the need for some kind of regulation of these proliferating sources of 
knowledge, advice and influence.  
 
It is impossible to predict the speed with which these new ways of organising access to expert 
knowledge will spread and the degree to which they will be incorporated by either public health 
services or private actors. Investments over the past few decades have resulted in the creation 
of quite complex health systems in most countries. They have also spread knowledge of modern 
medicine and raised expectations of how sickness should be treated. New information and 
communications technologies are creating platforms for organising the provision of health 
services and the dissemination of expert knowledge. This is creating opportunities for the 
emergence of new kinds of organisation to meet the largely unmet demands of growing 
numbers of people in many countries in quite distinctive ways. The ownership, management and 
regulation of these expert knowledge systems and of the various sources of expert knowledge 
will strongly influence the future development of health technology and the organisations to 
make the benefits widely available. This local level innovation remains ‘under the radar’ yet is 
likely to determine the larger pathways of change in the health systems of the future. 
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